MEGAN ALLISON: Open Payments
NPI 1003273087 · LYNCHBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$878 in 45 payments from 9 companies in 2025. Trend: 2023 $1,029 · 2024 $733 · 2025 $878
Food & beverage: $721Education: $157
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $382 |
| Janssen Biotech, Inc. | 15 | $252 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $99 |
| GENZYME CORPORATION | 3 | $48 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Blueprint Medicines Corporation | 1 | $21 |
| Incyte Corporation | 1 | $19 |
| Arcutis Biotherapeutics, Inc. | 1 | $16 |
| Amgen Inc. | 1 | $14 |
Products named: SKYRIZI, TREMFYA, RINVOQ, DUPIXENT, AYVAKIT, OPZELURA, Zoryve, OTEZLA.
Industry payments across VA — which companies pay providers there.
